Pediapharm Inc. (CVE:PDP – Get Free Report) rose 1.7% during trading on Friday . The stock traded as high as C$0.31 and last traded at C$0.30. Approximately 26,000 shares traded hands during trading, a decline of 74% from the average daily volume of 100,369 shares. The stock had previously closed at C$0.30.
Pediapharm Price Performance
The firm has a market capitalization of C$66.36 million and a PE ratio of -4.11. The firm’s fifty day moving average price is C$0.30 and its 200 day moving average price is C$0.30. The company has a current ratio of 1.12, a quick ratio of 0.71 and a debt-to-equity ratio of 186.87.
About Pediapharm
Pediapharm Inc operates as a specialty pharmaceutical company in Canada. It distributes prescription medicines that are used to treat pathological conditions, which primarily affect children from infancy to 18 years of age; and commercializes non-prescription products, such as non-prescription drugs and medical devices that fulfill unmet medical needs of children.
Featured Articles
- Five stocks we like better than Pediapharm
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- AI Demand Sparks Opportunities for These 3 Nuclear Energy Leaders
- Stock Sentiment Analysis: How it Works
- TSMC: Long-Term Outlook Still Strong as Geopolitical Risk Rises
- What is the Nasdaq? Complete Overview with History
- Uber’s NVIDIA Deal and Buybacks Signal Major Upside
Receive News & Ratings for Pediapharm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pediapharm and related companies with MarketBeat.com's FREE daily email newsletter.
